Promotions & Moves
-
Industry News | Promotions & Moves
LabVantage Solutions Names New CEO
John Heiser replaces LabVantage president Ram Velidi, who is leaving the company to pursue a new entrepreneurial endeavor09.25.18
-
Bio News | Industry News | Promotions & Moves
PharmaBlock Appoints CTO
Dr. Shijie Zhang brings over 20 years of combined experience in medicinal chemistry, process chemistry, and API manufacturing09.24.18
-
Industry News | Promotions & Moves
Astellas Announces Key Promotion
Geoff Towle has been promoted to vice president, Oncology Marketing, Astellas US09.19.18
-
Bio News | Industry News | Promotions & Moves
Metrion Announces Executive Appointments
Dr Edward Stevens joins as head of Drug Discovery, and Dr Andrew Lightfoot as head of Medicinal Chemistry & Discovery Funding09.17.18
-
Bio News | Industry News | Promotions & Moves
Particle Sciences Appoints President
Dr. Robert Lee has a decade of service at the company, most recently as executive vice president of Pharmaceutical Services09.13.18
-
Bio News | Facilities | Industry News | Promotions & Moves
TriLink BioTechnologies to Move to New Facility
Will consolidate its San Diego facilities into a new 95,000-square-foot space with an option to expand for future growth09.12.18
-
Promotions & Moves
Romaco Appoints Managing Director
Regner takes over at the Karlsruhe, Germany facility where Noack and Siebler brands are manufactured09.12.18
-
Bio News | Industry News | Promotions & Moves
Pfenex Announces New COO
Dr. Shawn A. Scranton joins the company with two decades of industry experience09.11.18
-
Bio News | Industry News | Promotions & Moves | R&D
Codiak BioSciences Appoints EVP
Dr. Robert M. Brenner will also serve as head of Research and Development at the company09.11.18
-
APIs | Bio News | Industry News | Promotions & Moves
TAPI Announces New President
John Nason joins TAPI after serving as Senior Vice President of European Technical Operations of Teva since 201509.10.18
-
Bio News | Industry News | Promotions & Moves
Achillion Pharmaceuticals Appoints EVP & COO
Paul Firuta has 27 years of experience building commercial organizations & launching products targeting rare diseases09.10.18
-
Bio News | Breaking News | Drug Development | Drug Discovery | Industry News | Promotions & Moves | R&D
Aileron Therapeutics Names President & CEO
Manuel Aivado, MD, PhD has over 20 years experience, and has served as Aileron’s SVP, CMO, and CSO since 201209.06.18
-
Bio News | Clinical Trials | Industry News | Promotions & Moves
Altasciences Appoints Clinical Trial Consultant
Dr. William J. Foster, MD, PhD, FRCSC is a practicing retinal physician in Montreal, Canada09.06.18
-
Bio News | Industry News | Promotions & Moves
Probiodrug Appoints Business & Strategy EVP
Dr. Michael Schaeffer brings more than 15 years of experience across pharma and biotech in strategic business development09.04.18
-
Bio News | Breaking News | Industry News | Promotions & Moves
Rehan Verjee to Lead EMD Serono
Mr. Verjee will take accountability for the U.S. and Canada biopharmaceutical business08.31.18
-
Promotions & Moves
Lilly Appoints SVP, Oncology President
White brings more than 25 years of experience in the pharmaceutical industry08.31.18
-
Analytical Services | Bio News | Drug Development | Industry News | Promotions & Moves
UPM Appoints Analytical Development Director
Dr. Chi-Chang Wung joins the company with more than two decades of industry experience08.29.18
-
Bio News | Industry News | Promotions & Moves
Roche Diagnostics CEO to Resign
Roland Diggelmann will pursue his career outside of Roche after years of working with the company08.28.18
-
Bio News | Industry News | Promotions & Moves
APEIRON Appoints CMSO
Dr. Anderson Gaweco joins from Innovimmune Biotherapeutics where he was founder, chief executive & scientific officer08.28.18
-
Bio News | Industry News | Promotions & Moves
Arcturus Therapeutics Appoints Interim CFO
Andrew Sassine was named Interim chief financial officer, effective August 24, 201808.28.18
